Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Comment light on for FDA and tobacco

This article was originally published in The Tan Sheet

Executive Summary

FDA solicits public comment on topics concerning its authority over tobacco products established by recently enacted Family Smoking Prevention and Tobacco Control Act, including smoking cessation, prevention and federal, state and local government collaboration. After the Center for Tobacco Products required by the law is established, FDA will seek comment on more specific issues on reducing the incidence and prevalence of tobacco use and protecting public health, according to a July 1 Federal Register notice (1"The Tan Sheet" June 15, 2008). Also included among the comment topics are new product submission and approval; ingredient disclosure; tobacco use by specific groups; tobacco addiction; data collection; products with reduced harm/risk claims; enforcement; research and testing; advertising and marketing; label statements and warnings; standards - including flavors and ingredients; sale and distribution; and manufacturing restrictions and facilities controls. The deadline for comments is Oct. 28

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103084

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel